Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drug Intermediates CDMO Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Process Optimization of Generic Intermediates
1.2.3 Production of Generic Intermediates
1.3 Market by Application
1.3.1 Global Generic Drug Intermediates CDMO Services Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Enterprise
1.3.3 Laboratory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drug Intermediates CDMO Services Market Perspective (2018-2033)
2.2 Generic Drug Intermediates CDMO Services Growth Trends by Region
2.2.1 Global Generic Drug Intermediates CDMO Services Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Generic Drug Intermediates CDMO Services Historic Market Size by Region (2018-2023)
2.2.3 Generic Drug Intermediates CDMO Services Forecasted Market Size by Region (2024-2033)
2.3 Generic Drug Intermediates CDMO Services Market Dynamics
2.3.1 Generic Drug Intermediates CDMO Services Industry Trends
2.3.2 Generic Drug Intermediates CDMO Services Market Drivers
2.3.3 Generic Drug Intermediates CDMO Services Market Challenges
2.3.4 Generic Drug Intermediates CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drug Intermediates CDMO Services Players by Revenue
3.1.1 Global Top Generic Drug Intermediates CDMO Services Players by Revenue (2018-2023)
3.1.2 Global Generic Drug Intermediates CDMO Services Revenue Market Share by Players (2018-2023)
3.2 Global Generic Drug Intermediates CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Drug Intermediates CDMO Services Revenue
3.4 Global Generic Drug Intermediates CDMO Services Market Concentration Ratio
3.4.1 Global Generic Drug Intermediates CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drug Intermediates CDMO Services Revenue in 2022
3.5 Generic Drug Intermediates CDMO Services Key Players Head office and Area Served
3.6 Key Players Generic Drug Intermediates CDMO Services Product Solution and Service
3.7 Date of Enter into Generic Drug Intermediates CDMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drug Intermediates CDMO Services Breakdown Data by Type
4.1 Global Generic Drug Intermediates CDMO Services Historic Market Size by Type (2018-2023)
4.2 Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Type (2024-2033)
5 Generic Drug Intermediates CDMO Services Breakdown Data by Application
5.1 Global Generic Drug Intermediates CDMO Services Historic Market Size by Application (2018-2023)
5.2 Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Generic Drug Intermediates CDMO Services Market Size (2018-2033)
6.2 North America Generic Drug Intermediates CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023)
6.4 North America Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Drug Intermediates CDMO Services Market Size (2018-2033)
7.2 Europe Generic Drug Intermediates CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023)
7.4 Europe Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Drug Intermediates CDMO Services Market Size (2018-2033)
8.2 Asia-Pacific Generic Drug Intermediates CDMO Services Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Generic Drug Intermediates CDMO Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Generic Drug Intermediates CDMO Services Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Drug Intermediates CDMO Services Market Size (2018-2033)
9.2 Latin America Generic Drug Intermediates CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023)
9.4 Latin America Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drug Intermediates CDMO Services Market Size (2018-2033)
10.2 Middle East & Africa Generic Drug Intermediates CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Euroapi
11.1.1 Euroapi Company Detail
11.1.2 Euroapi Business Overview
11.1.3 Euroapi Generic Drug Intermediates CDMO Services Introduction
11.1.4 Euroapi Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.1.5 Euroapi Recent Development
11.2 Cambrex
11.2.1 Cambrex Company Detail
11.2.2 Cambrex Business Overview
11.2.3 Cambrex Generic Drug Intermediates CDMO Services Introduction
11.2.4 Cambrex Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.2.5 Cambrex Recent Development
11.3 Recipharm
11.3.1 Recipharm Company Detail
11.3.2 Recipharm Business Overview
11.3.3 Recipharm Generic Drug Intermediates CDMO Services Introduction
11.3.4 Recipharm Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.3.5 Recipharm Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Introduction
11.4.4 Thermo Fisher Scientific Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Wuxi New Drug Development
11.5.1 Wuxi New Drug Development Company Detail
11.5.2 Wuxi New Drug Development Business Overview
11.5.3 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Introduction
11.5.4 Wuxi New Drug Development Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.5.5 Wuxi New Drug Development Recent Development
11.6 Pharmaron Beijing
11.6.1 Pharmaron Beijing Company Detail
11.6.2 Pharmaron Beijing Business Overview
11.6.3 Pharmaron Beijing Generic Drug Intermediates CDMO Services Introduction
11.6.4 Pharmaron Beijing Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.6.5 Pharmaron Beijing Recent Development
11.7 Asymchem Laboratories
11.7.1 Asymchem Laboratories Company Detail
11.7.2 Asymchem Laboratories Business Overview
11.7.3 Asymchem Laboratories Generic Drug Intermediates CDMO Services Introduction
11.7.4 Asymchem Laboratories Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.7.5 Asymchem Laboratories Recent Development
11.8 Porton Pharma Solutions
11.8.1 Porton Pharma Solutions Company Detail
11.8.2 Porton Pharma Solutions Business Overview
11.8.3 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Introduction
11.8.4 Porton Pharma Solutions Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.8.5 Porton Pharma Solutions Recent Development
11.9 ChengDa Pharmaceuticals
11.9.1 ChengDa Pharmaceuticals Company Detail
11.9.2 ChengDa Pharmaceuticals Business Overview
11.9.3 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Introduction
11.9.4 ChengDa Pharmaceuticals Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.9.5 ChengDa Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Generic Drug Intermediates CDMO Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Process Optimization of Generic Intermediates
Table 3. Key Players of Production of Generic Intermediates
Table 4. Global Generic Drug Intermediates CDMO Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Generic Drug Intermediates CDMO Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Generic Drug Intermediates CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Generic Drug Intermediates CDMO Services Market Share by Region (2018-2023)
Table 8. Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Generic Drug Intermediates CDMO Services Market Share by Region (2024-2033)
Table 10. Generic Drug Intermediates CDMO Services Market Trends
Table 11. Generic Drug Intermediates CDMO Services Market Drivers
Table 12. Generic Drug Intermediates CDMO Services Market Challenges
Table 13. Generic Drug Intermediates CDMO Services Market Restraints
Table 14. Global Generic Drug Intermediates CDMO Services Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Generic Drug Intermediates CDMO Services Market Share by Players (2018-2023)
Table 16. Global Top Generic Drug Intermediates CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug Intermediates CDMO Services as of 2022)
Table 17. Ranking of Global Top Generic Drug Intermediates CDMO Services Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Generic Drug Intermediates CDMO Services Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Generic Drug Intermediates CDMO Services Product Solution and Service
Table 21. Date of Enter into Generic Drug Intermediates CDMO Services Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Generic Drug Intermediates CDMO Services Revenue Market Share by Type (2018-2023)
Table 25. Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Generic Drug Intermediates CDMO Services Revenue Market Share by Type (2024-2033)
Table 27. Global Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Generic Drug Intermediates CDMO Services Revenue Market Share by Application (2018-2023)
Table 29. Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Generic Drug Intermediates CDMO Services Revenue Market Share by Application (2024-2033)
Table 31. North America Generic Drug Intermediates CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Generic Drug Intermediates CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Generic Drug Intermediates CDMO Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Generic Drug Intermediates CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Generic Drug Intermediates CDMO Services Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Generic Drug Intermediates CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Generic Drug Intermediates CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 46. Euroapi Company Detail
Table 47. Euroapi Business Overview
Table 48. Euroapi Generic Drug Intermediates CDMO Services Product
Table 49. Euroapi Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 50. Euroapi Recent Development
Table 51. Cambrex Company Detail
Table 52. Cambrex Business Overview
Table 53. Cambrex Generic Drug Intermediates CDMO Services Product
Table 54. Cambrex Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 55. Cambrex Recent Development
Table 56. Recipharm Company Detail
Table 57. Recipharm Business Overview
Table 58. Recipharm Generic Drug Intermediates CDMO Services Product
Table 59. Recipharm Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 60. Recipharm Recent Development
Table 61. Thermo Fisher Scientific Company Detail
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Product
Table 64. Thermo Fisher Scientific Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Wuxi New Drug Development Company Detail
Table 67. Wuxi New Drug Development Business Overview
Table 68. Wuxi New Drug Development Generic Drug Intermediates CDMO Services Product
Table 69. Wuxi New Drug Development Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 70. Wuxi New Drug Development Recent Development
Table 71. Pharmaron Beijing Company Detail
Table 72. Pharmaron Beijing Business Overview
Table 73. Pharmaron Beijing Generic Drug Intermediates CDMO Services Product
Table 74. Pharmaron Beijing Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 75. Pharmaron Beijing Recent Development
Table 76. Asymchem Laboratories Company Detail
Table 77. Asymchem Laboratories Business Overview
Table 78. Asymchem Laboratories Generic Drug Intermediates CDMO Services Product
Table 79. Asymchem Laboratories Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 80. Asymchem Laboratories Recent Development
Table 81. Porton Pharma Solutions Company Detail
Table 82. Porton Pharma Solutions Business Overview
Table 83. Porton Pharma Solutions Generic Drug Intermediates CDMO Services Product
Table 84. Porton Pharma Solutions Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 85. Porton Pharma Solutions Recent Development
Table 86. ChengDa Pharmaceuticals Company Detail
Table 87. ChengDa Pharmaceuticals Business Overview
Table 88. ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Product
Table 89. ChengDa Pharmaceuticals Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 90. ChengDa Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Drug Intermediates CDMO Services Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Generic Drug Intermediates CDMO Services Market Share by Type: 2022 VS 2033
Figure 3. Process Optimization of Generic Intermediates Features
Figure 4. Production of Generic Intermediates Features
Figure 5. Global Generic Drug Intermediates CDMO Services Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Generic Drug Intermediates CDMO Services Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical Enterprise Case Studies
Figure 8. Laboratory Case Studies
Figure 9. Other Case Studies
Figure 10. Generic Drug Intermediates CDMO Services Report Years Considered
Figure 11. Global Generic Drug Intermediates CDMO Services Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Generic Drug Intermediates CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Generic Drug Intermediates CDMO Services Market Share by Region: 2022 VS 2033
Figure 14. Global Generic Drug Intermediates CDMO Services Market Share by Players in 2022
Figure 15. Global Top Generic Drug Intermediates CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug Intermediates CDMO Services as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Generic Drug Intermediates CDMO Services Revenue in 2022
Figure 17. North America Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Generic Drug Intermediates CDMO Services Market Share by Country (2018-2033)
Figure 19. United States Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Generic Drug Intermediates CDMO Services Market Share by Country (2018-2033)
Figure 23. Germany Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Generic Drug Intermediates CDMO Services Market Share by Region (2018-2033)
Figure 31. China Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Generic Drug Intermediates CDMO Services Market Share by Country (2018-2033)
Figure 39. Mexico Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Generic Drug Intermediates CDMO Services Market Share by Country (2018-2033)
Figure 43. Turkey Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Euroapi Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 46. Cambrex Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 47. Recipharm Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 49. Wuxi New Drug Development Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 50. Pharmaron Beijing Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 51. Asymchem Laboratories Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 52. Porton Pharma Solutions Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 53. ChengDa Pharmaceuticals Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed